SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MCAR
MCAR 0.0650-36.3%Jan 31 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LORD ERNIE who wrote (440)9/24/1999 12:56:00 PM
From: LORD ERNIE   of 467
 
Bruce Byots Joins MedCare Technologies as Director, Investor Relations

OAK BROOK, Ill., Sep 20, 1999 (BUSINESS WIRE) -- MedCare Technologies,
Inc. (NASDAQ: MCAR) announced today that Bruce Byots has joined the
company as Director, Investor Relations. Byots will be responsible for
developing, implementing and managing MedCare's overall investor and
media relations program.

Byots joins the company from Stone Container Corporation (now
Smurfit-Stone Container Corporation), where he most recently served as
Director of Investor Relations. He joined Stone in 1984 and was
responsible for a variety of finance and treasury functions. He has
fifteen-plus years of investor and financial relations experience and
holds a B.S. in Finance from De Paul University.

"We are very pleased to have Bruce join our team," said Jeff Aronin,
President and Chief Executive Officer. "We have come a long way since
conceptualizing and developing our MedCare Program, which is now
regarded as the leading non-drug, non-surgical treatment program for
millions of urinary incontinence sufferers. "Therefore, we feel it is
now the appropriate strategic point to add someone like Bruce to help
us further develop our investor and media relations strategy."

MedCare Technologies, Inc. is a healthcare technology service company
that focuses on under-served high growth markets.

Its core business, the MedCare Program, is the leading and most
comprehensive conservative therapy for treating incontinence, a hidden
health condition that, at approximately $26 billion, costs more than
diabetes and bypass surgery combined.

This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements include statements concerning plans, objectives, goals,
strategies, future events or performance and underlying assumptions and
other statements which are other than statements of historical facts.
These statements are subject to uncertainties and risks including, but
not limited to, product and service demand and acceptance, changes in
technology, changes in insurance reimbursement, economic conditions,
the impact of competition and pricing, government regulation, and other
risks defined in this document and in statements filed from time to
time with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether made
by or on behalf of the Company are expressly qualified by these
cautionary statements and any other cautionary statements which may
accompany the forward-looking statements. In addition, the Company
disclaims any obligation to update any forward-looking statements to
reflect events or circumstances after the date hereof.

Copyright (C) 1999 Business Wire. All rights reserved.

Distributed via COMTEX.


CONTACT: MedCare Technologies, Inc.
Bruce Byots, Investor Relations Department,
1-800-611-2288
Website: www.medcareonline.com
or
MedCare Technologies, Inc.
Bill Mann, Manager, 800/611-2288

WEB PAGE: businesswire.com



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext